Item 5.02 - Executive Leadership Changes: Filing reports departure of directors or certain officers, election of directors, and appointment of certain officers as of February 2, 2026 Compensatory Arrangements: Document includes disclosure of compensatory arrangements related to officer appointments or departures Filing Date: Current report filed on February 5, 2026, for events occurring on…

Our analysis rates this filing BULLISH. This 8-K filing reports a routine board composition change with minimal material concern. Yoshiaki Fujimori's announced non-reelection at the 2026 Annual Meeting represents standard director turnover rather than a governance crisis. The departure is…

Concern level: MODERATE (2.1/10). Key factors: Board leadership transition: Loss of Risk, Science and Technology Committee chair with 9+ years tenure; Temporary governance gap during committee chair succession period until 2026 Annual Meeting; Uncertainty regarding board composition replacement decisions.

Notable risk changes: Yoshiaki Fujimori announced he will not seek re-election at 2026 Annual Meeting; has served since July 2016 as Risk, Science and Technology Committee chair; Departure is orderly and non-contentious - explicitly stated as not due to disagreement with company; Board and Nominating Committee will evaluate whether to replace the departing director, leaving board composition flexible.

The model predicts BSX will underperform the S&P 500 by about 0.0% over 30 days. This is model analysis for research, not investment advice.